208 related articles for article (PubMed ID: 32316907)
1. Metal-organic Nanopharmaceuticals.
Steinborn B; Lächelt U
Pharm Nanotechnol; 2020; 8(3):163-190. PubMed ID: 32316907
[TBL] [Abstract][Full Text] [Related]
2. Recent Developments of Supramolecular Metal-based Structures for Applications in Cancer Therapy and Imaging.
Pöthig A; Casini A
Theranostics; 2019; 9(11):3150-3169. PubMed ID: 31244947
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.
He L; Liu Y; Lau J; Fan W; Li Q; Zhang C; Huang P; Chen X
Nanomedicine (Lond); 2019 May; 14(10):1343-1365. PubMed ID: 31084393
[TBL] [Abstract][Full Text] [Related]
4. Recent development of amorphous metal coordination polymers for cancer therapy.
Liu Y; Lv S; Liu D; Song F
Acta Biomater; 2020 Oct; 116():16-31. PubMed ID: 32942012
[TBL] [Abstract][Full Text] [Related]
5. Prospective of nanoscale metal organic frameworks [NMOFs] for cancer therapy.
Shait Mohammed MR; Ahmad V; Ahmad A; Tabrez S; Choudhry H; Zamzami MA; Bakhrebah MA; Ahmad A; Wasi S; Mukhtar H; Khan MI
Semin Cancer Biol; 2021 Feb; 69():129-139. PubMed ID: 31866477
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.
Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H
ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871
[TBL] [Abstract][Full Text] [Related]
7. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
8. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
[TBL] [Abstract][Full Text] [Related]
9. Microwave-Assisted Synthesis, Characterization and Modeling of CPO-27-Mg Metal-Organic Framework for Drug Delivery.
Kudelin AI; Papathanasiou K; Isaeva V; Caro J; Salmi T; Kustov LM
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467467
[TBL] [Abstract][Full Text] [Related]
10. Metal-Organic Framework Nanoparticle-Based Biomineralization: A New Strategy toward Cancer Treatment.
Chu C; Su M; Zhu J; Li D; Cheng H; Chen X; Liu G
Theranostics; 2019; 9(11):3134-3149. PubMed ID: 31244946
[TBL] [Abstract][Full Text] [Related]
11. Metal-organic frameworks: mechanisms of antibacterial action and potential applications.
Wyszogrodzka G; Marszałek B; Gil B; Dorożyński P
Drug Discov Today; 2016 Jun; 21(6):1009-18. PubMed ID: 27091434
[TBL] [Abstract][Full Text] [Related]
12. Stimuli-responsive metal-organic framework nanoparticles for controlled drug delivery and medical applications.
Zhou Z; Vázquez-González M; Willner I
Chem Soc Rev; 2021 Apr; 50(7):4541-4563. PubMed ID: 33625421
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive multifunctional metal-organic framework nanoparticles for enhanced chemo-photothermal therapy.
Feng J; Xu Z; Dong P; Yu W; Liu F; Jiang Q; Wang F; Liu X
J Mater Chem B; 2019 Feb; 7(6):994-1004. PubMed ID: 32255104
[TBL] [Abstract][Full Text] [Related]
14. Bioengineering of Metal-organic Frameworks for Nanomedicine.
Liu Y; Zhao Y; Chen X
Theranostics; 2019; 9(11):3122-3133. PubMed ID: 31244945
[TBL] [Abstract][Full Text] [Related]
15. Nanosoldiers: A promising strategy to combat triple negative breast cancer.
Pawar A; Prabhu P
Biomed Pharmacother; 2019 Feb; 110():319-341. PubMed ID: 30529766
[TBL] [Abstract][Full Text] [Related]
16. Evaluating UiO-66 Metal-Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications.
Jarai BM; Stillman Z; Attia L; Decker GE; Bloch ED; Fromen CA
ACS Appl Mater Interfaces; 2020 Sep; 12(35):38989-39004. PubMed ID: 32805901
[TBL] [Abstract][Full Text] [Related]
17. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled multifunctional core-shell highly porous metal-organic framework nanoparticles.
Qiu J; Li X; Steenkeste K; Barroca-Aubry N; Aymes-Chodur C; Roger P; Casas-Solvas JM; Vargas-Berenguel A; Rihouey C; Picton L; Gref R
Int J Pharm; 2020 May; 581():119281. PubMed ID: 32276089
[TBL] [Abstract][Full Text] [Related]
19. Carbon Dots Embedded Magnetic Nanoparticles @Chitosan @Metal Organic Framework as a Nanoprobe for pH Sensitive Targeted Anticancer Drug Delivery.
Chowdhuri AR; Singh T; Ghosh SK; Sahu SK
ACS Appl Mater Interfaces; 2016 Jul; 8(26):16573-83. PubMed ID: 27305490
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
